4Q Revenue of $1.355 billion; 68% reported growth; 65% organic growth 4Q GAAP EPS from continuing operations of $3.38; Adjusted EPS of $3.96 Initiates First Quarter and Full Year 2021 Guidance WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 2, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for... Read more
Centricity Cardiology Enterprise ranked first amongst competitors by the industry-trusted research and insights firm. CHICAGO, Ill., February 2, 2021 – GE Healthcare has been named Best in KLAS for Cardiology IT by KLAS, an industry-trusted research and insights firm, for its Centricity™ Cardiology Enterprise[1] solution. The Best in KLAS 2021 Software and Services Report ranks... Read more
WALTHAM, Mass., Feb. 1, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter and Full Year 2020 Highlights Fourth quarter revenue grew 54% to $10.55 billion. Fourth quarter GAAP diluted earnings... Read more
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of... Read more
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of... Read more
MENLO PARK, Calif., Jan. 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 110,000 shares of... Read more
WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a “Best Place to Work for LGBTQ Equality” for the sixth consecutive year. The company received a perfect score on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s 19th annual scorecard on... Read more
WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a “Best Place to Work for LGBTQ Equality” for the sixth consecutive year. The company received a perfect score on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s 19th annual scorecard on... Read more
Thermo Fisher Scientific Named “Best Place to Work for LGBTQ Equality” for Sixth Consecutive Year WALTHAM, Mass., Jan. 29, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, was recognized as a “Best Place to Work for LGBTQ Equality” for the sixth consecutive year. The company received a perfect score on... Read more
WASHINGTON, Jan. 28, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2020. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2020, net earnings were $1.2 billion, or $1.66 per diluted common share which represents a... Read more